Needham & Company LLC Boosts CVS Health (CVS) Price Target to $85.00

Adjust Comment Print

About 12.37M shares traded or 42.44% up from the average. Commonwealth Equity Inc has invested 0.01% of its portfolio in Packaging Corporation of America (NYSE:PKG). It has outperformed by 36.17% the S&P500.

Endurant Capital Management Lp decreased Cvs Health Corp (CVS) stake by 16.87% reported in 2017Q2 SEC filing.

CVS Health (NYSE:CVS) opened at $71.38 on Monday. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator's stock valued at $105,000 after buying an additional 991 shares during the last quarter. Its share price has decline -11.23% in three months and is down -2.75% for the last five trades.


CVS Health Corporation (NYSE:CVS) has seen its stock price gain 7.90, or -10.01%, so far in 2017. It has underperformed by 41.10% the S&P500. Needham & Company LLC upgraded CVS Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $69.02 to $79.00 in a report on Friday, November 10th. Therefore 68% are positive. Also, EVP Thomas M. Moriarty sold 90,267 shares of CVS Health stock in a transaction on Monday, September 11th. Piper Jaffray maintained the shares of AMZN in report on Friday, July 24 with "Overweight" rating. As per Monday, October 12, the company rating was maintained by Susquehanna. The rating was downgraded by Jefferies on Monday, December 12 to "Hold". The firm has "Outperform" rating given on Wednesday, January 25 by BMO Capital Markets. The firm has "Buy" rating given on Wednesday, August 19 by Evercore. Wolfe Research lowered CVS Health from an "outperform" rating to a "market perform" rating and decreased their price objective for the company from $89.00 to $82.00 in a research note on Monday, August 14th. Kimball Intl Inc now has $674.91 million valuation.

CVS Health Corporation (NYSE:CVS), at its latest closing price of $71.38, it has a price-to-book ratio of 2.06, compared to an industry average at 3.03. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67 % EPS growth. CVS's profit will be $1.92 billion for 9.38 P/E if the $1.90 EPS becomes a reality. The pharmacy operator reported $1.50 earnings per share for the quarter, beating analysts' consensus estimates of $1.49 by $0.01. The J.M. Smucker Company (NYSE:SJM) has declined 0.84% since December 6, 2016 and is downtrending. The stock of CVS Health Corporation (NYSE:CVS) has "Neutral" rating given on Monday, May 9 by Citigroup.

Investors sentiment decreased to 0.92 in 2017 Q2. The company maintains price to book ratio of 0.96 vs.an industry average at 4.07. It fall, as 84 investors sold CVS shares while 559 reduced holdings. Several hedge funds have recently made changes to their positions in CVS. Highstreet Asset Management Incorporated has 0.35% invested in CVS Health Corporation (NYSE:CVS) for 40,270 shares.


CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. Autus Asset Mngmt Ltd Limited Liability Company reported 0.15% stake. Lowe Brockenbrough & Communication accumulated 29,908 shares. Bnp Paribas Arbitrage Sa holds 720,326 shares or 0.17% of its portfolio. Sfe Invest Counsel invested in 0.62% or 18,855 shares. Mirae Asset Limited holds 0.08% of its portfolio in CVS Health Corporation (NYSE:CVS) for 56,718 shares.

ILLEGAL ACTIVITY NOTICE: "Nationwide Fund Advisors Reduces Position in CVS Health Corp (NYSE:CVS)" was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. United Services Automobile Association reported 1.44 million shares. Jnba Advisors reported 5,997 shares. Public Employees Retirement System of OH now owns 728,256 shares of the pharmacy operator's stock worth $59,222,000 after acquiring an additional 2,594 shares in the last quarter. Insur Communication Tx accumulated 129,754 shares. Following the completion of the transaction, the executive vice president now directly owns 94,309 shares of the company's stock, valued at approximately $7,424,947.57. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator's stock valued at $2,353,000 after purchasing an additional 982 shares during the period. Citigroup has "Neutral" rating and $76 target. (NYSE:C) earned "Buy" rating by BMO Capital Markets on Friday, July 14. Goldman Sachs initiated the stock with "Sell" rating in Thursday, September 22 report. Mizuho maintained the shares of CVS in report on Thursday, June 23 with "Buy" rating. Vetr upgraded it to "Buy" rating and $117.98 target in Monday, August 24 report. Mizuho has "Buy" rating and $108 target. On Wednesday, April 27 the stock rating was maintained by Deutsche Bank with "Buy". The rating was maintained by Jefferies on Thursday, July 14 with "Buy". In the past 3-month period alone, shares of CVS have appreciated -7.68 - or -9.76%.

Investors sentiment decreased to 0.8 in Q2 2017. Its up 0.21, from 1.08 in 2017Q1. It is negative, as 43 investors sold PKG shares while 167 reduced holdings. Fieldpoint Private Securities LLC increased its stake in CVS Health by 333.3% during the second quarter. 345.02 million shares or 4.03% more from 331.66 million shares in 2017Q1 were reported. Cambridge Investment Research Advsr invested 0.03% of its portfolio in Twitter, Inc. Jennison Ltd Liability stated it has 0% in CVS Health Corporation (NYSE:CVS). Van Den Berg I, Texas-based fund reported 128,362 shares. South Dakota Invest Council reported 11,200 shares. Sterling Capital Mgmt Ltd reported 9,618 shares. First Limited Partnership reported 896,682 shares. Community Comml Bank Na has invested 0% in Twitter, Inc. (NYSE:TWTR). Nomura Asset Ltd has invested 0.02% of its portfolio in Twitter, Inc. Nj State Employees Deferred Compensation Plan stated it has 0.1% in Citigroup Inc. (NYSE:TWTR). Jpmorgan Chase & Com holds 1.21 million shares or 0% of its portfolio.


Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Comments